Your browser doesn't support javascript.
loading
Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients.
Flerlage, Jamie E; von Buttlar, Xinyu; Krasin, Matthew; Triplett, Brandon; Kaste, Sue C; Metzger, Monika L.
Afiliação
  • Flerlage JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • von Buttlar X; University of Tennessee Health Sciences Center, Memphis, Tennessee.
  • Krasin M; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Triplett B; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Kaste SC; Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Metzger ML; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
Pediatr Blood Cancer ; 66(12): e27962, 2019 12.
Article em En | MEDLINE | ID: mdl-31429511
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Terapia de Salvação / Antineoplásicos Imunológicos / Brentuximab Vedotin Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Terapia de Salvação / Antineoplásicos Imunológicos / Brentuximab Vedotin Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article